Idarubicin, cytarabine in standard or high-dose, and etoposide+- lenograstim (G-CSF) for adult acute myeloid leukemia (AML).  Combinations giving high remission rates

Lowenthal, Raymond; Bradstock, KM; Matthews, JP; Enno, A; Gill, D; Page, FJ; Rooney, Kim; Taylor, KM

File(s) not publicly available

Idarubicin, cytarabine in standard or high-dose, and etoposide+- lenograstim (G-CSF) for adult acute myeloid leukemia (AML). Combinations giving high remission rates

conference contribution

posted on 2023-05-23, 19:25 authored by Raymond Lowenthal, Bradstock, KM, Matthews, JP, Enno, A, Gill, D, Page, FJ, Kim RooneyKim Rooney, Taylor, KM

No description available

History

Pagination

768a

Department/School

Tasmanian School of Medicine

Publisher

Proceeding

Event title

American Society of Hematology 37th Annual Meeting, 1-5 December

Event Venue

Seattle, USA

Date of Event (Start Date)

1995-01-01

Date of Event (End Date)

1995-01-01

Repository Status

Restricted

Socio-economic Objectives

Other health not elsewhere classified

Usage metrics

Keywords

No keyword provided

Licence

In Copyright

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC